|
US103A
(en)
|
|
1836-12-10 |
|
Process |
|
US8669A
(en)
|
|
1852-01-20 |
|
John waters |
|
US4812409A
(en)
|
1986-01-31 |
1989-03-14 |
Eastman Kodak Company |
Hydrolyzable fluorescent substrates and analytical determinations using same
|
|
US4810636A
(en)
|
1986-12-09 |
1989-03-07 |
Miles Inc. |
Chromogenic acridinone enzyme substrates
|
|
US5368484A
(en)
|
1992-05-22 |
1994-11-29 |
Atari Games Corp. |
Vehicle simulator with realistic operating feedback
|
|
US6162931A
(en)
|
1996-04-12 |
2000-12-19 |
Molecular Probes, Inc. |
Fluorinated xanthene derivatives
|
|
US7393656B2
(en)
|
2001-07-10 |
2008-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for risk stratification
|
|
US7268229B2
(en)
|
2001-11-02 |
2007-09-11 |
Promega Corporation |
Compounds to co-localize luminophores with luminescent proteins
|
|
US7429472B2
(en)
|
2003-01-31 |
2008-09-30 |
Promega Corporation |
Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
|
|
EP1594962B1
(en)
|
2003-01-31 |
2014-08-27 |
Promega Corporation |
Covalent tethering of functional groups to proteins
|
|
US7425436B2
(en)
|
2004-07-30 |
2008-09-16 |
Promega Corporation |
Covalent tethering of functional groups to proteins and substrates therefor
|
|
WO2007016975A1
(en)
*
|
2005-07-29 |
2007-02-15 |
F. Hoffmann-La Roche Ag |
Kinase and phosphatase assays based on fret
|
|
AR065015A1
(es)
*
|
2007-01-26 |
2009-05-13 |
Smithkline Beecham Corp |
Derivados de antranilamida, composiciones farmaceuticas que los contienen, y usos para el tratamiento del cancer
|
|
ES2795287T3
(es)
|
2009-05-01 |
2020-11-23 |
Promega Corp |
Luciferasas de Oplophorus sintéticas con mayor emisión de luz
|
|
SG10202103336SA
(en)
|
2010-11-02 |
2021-04-29 |
Promega Corp |
Novel coelenterazine substrates and methods of use
|
|
US20140099654A1
(en)
|
2012-09-26 |
2014-04-10 |
Promega Corporation |
Real-time monitoring
|
|
ES2926463T3
(es)
|
2013-03-15 |
2022-10-26 |
Promega Corp |
Activación de la bioluminiscencia mediante complementación estructural
|
|
WO2014176700A1
(en)
*
|
2013-05-01 |
2014-11-06 |
Université de Montréal |
Biosensors for ras-dependent signaling pathways and use thereof
|
|
JP7092677B2
(ja)
|
2016-02-15 |
2022-06-28 |
プロメガ コーポレイション |
セレンテラジン類似体
|
|
JP7212612B2
(ja)
|
2016-07-28 |
2023-01-25 |
プロメガ コーポレイション |
セレンテラジン類縁体
|
|
US9943505B2
(en)
|
2016-09-09 |
2018-04-17 |
Corcept Therapeutics, Inc. |
Glucocorticoid receptor modulators to treat pancreatic cancer
|
|
US11442063B2
(en)
*
|
2018-05-30 |
2022-09-13 |
Promega Corporation |
Broad spectrum kinase binding agents
|